Cargando…
Benefits and limitations of serological assays in COVID-19 infection
Accurate and rapid diagnostic tests are critical for achieving control of coronavirus disease 2019 (covid-19), a pandemic illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Diagnostic tests for covid-19 fall into two main categories: molecular tests that detect viral RNA...
Autores principales: | Sidiq, Zeeshan, Hanif, M., Dwivedi, Kaushal Kumar, Chopra, K.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tuberculosis Association of India. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409828/ https://www.ncbi.nlm.nih.gov/pubmed/33308664 http://dx.doi.org/10.1016/j.ijtb.2020.07.034 |
Ejemplares similares
-
Laboratory diagnosis of novel corona virus (2019-nCoV)-present and the future
por: Sidiq, Zeeshan, et al.
Publicado: (2020) -
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
por: Karger, Amy B., et al.
Publicado: (2022) -
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
por: Karger, Amy B., et al.
Publicado: (2022) -
Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19
por: Tian, Linhua, et al.
Publicado: (2021) -
Identifying Recent HIV Infections: From Serological Assays to Genomics
por: Moyo, Sikhulile, et al.
Publicado: (2015)